Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa Due to SARS-CoV2 (TSUNAMI Study): a Multicenter Open Label Randomized Control Trial

NCT04716556 is registered in ClinicalTrials.gov with Istituto Superiore di Sanità as lead sponsor.

NCT NCT04716556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04716556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa Due to SARS-CoV2 (TSUNAMI Study): a Multicenter Open Label Randomized Control Trial
Lead sponsor
Istituto Superiore di Sanità
Phase
Not applicable
Overall status
Completed
Start date
July 16, 2020
Completion date
May 31, 2021
Enrollment
474 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, covid19, pneumonia, viral